Lakefront Biotherapeutics NV (LKFT)
NASDAQ: LKFT · Real-Time Price · USD
27.21
-0.43 (-1.56%)
Jul 31, 2026, 4:00 PM EDT - Market closed

LKFT Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,8092,1551,8122,6792,9223,614
Market Cap Growth
-17.50%18.91%-32.35%-8.32%-19.15%-44.18%
Enterprise Value
-1,615-1,355-1,420-1,384-1,446-1,704
Last Close Price
27.2132.7027.5040.6544.3855.13
PE Ratio
3.215.7223.6011.46--
PS Ratio
1.501.585.508.449.8211.33
PB Ratio
0.480.570.600.871.081.20
P/TBV Ratio
0.550.670.681.031.261.40
EV/Sales Ratio
--0.99-4.31-4.36-4.86-5.34
EV/EBITDA Ratio
--7.2428.0520.5910.94
EV/EBIT Ratio
--7.2414.1810.298.73
EV/FCF Ratio
-4.264.052.952.552.68
Debt / Equity Ratio
0.000.000.000.000.010.01
Debt / EBITDA Ratio
0.020.02----
Net Debt / Equity Ratio
-0.91-0.92-1.07-1.31-1.61-1.77
Net Debt / EBITDA Ratio
-7.63-8.5216.4982.3662.1834.15
Net Debt / FCF Ratio
9.5911.039.228.657.718.38
Asset Turnover
0.320.310.070.060.060.05
Inventory Turnover
1.040.810.56000
Quick Ratio
30.2319.959.568.767.968.53
Current Ratio
30.4820.159.979.028.118.58
Return on Equity (ROE)
14.01%9.20%-0.17%0.57%-2.72%-4.44%
Return on Assets (ROA)
11.10%7.34%-7.03%-5.26%-2.62%-3.11%
Return on Invested Capital (ROIC)
144.05%1545.26%----
Return on Capital Employed (ROCE)
11.95%8.36%-4.87%-2.17%-2.97%-3.53%
Earnings Yield
31.16%17.47%4.24%8.73%--
Buyback Yield / Dilution
-0.03%0.00%-0.02%-0.28%-0.30%-0.65%
Total Shareholder Return
-0.03%0.00%-0.02%-0.28%-0.30%-0.65%
SEC Filings: 10-K · 10-Q